Denemek ALTIN - Özgür
Centre May Relax Import Rules for E-buses, Trucks
Mint Mumbai
|September 13, 2025
India's electric mobility push may get a breather. The ministry of heavy industries is planning to allow electric truck and bus makers to import traction motors fitted with rare earth magnets without losing incentives under the ₹10,900-crore PME-Drive scheme, two officials aware of the development said.
However, any relief would be temporary, lasting only until China resumes rare earth magnet exports, one of the officials said, citing the recent thaw in relations between New Delhi and Beijing.
The policy tweak comes amid a supply crunch that threatens production.
Mint reported on 18 July that the Centre had tasked the Automotive Research Association of India (Arai) with assessing whether localization rules under the PME-Drive and the production-linked incentive (PLI) scheme for automobiles and auto parts should be relaxed, after appeals from the industry.
"Arai came back to us suggesting that the relaxation be given to electric trucks and buses. But not to two-wheelers and three-wheelers," said the other official cited above. Both officials spoke to Mint on the condition of anonymity.
Experts said the relaxation applies only to trucks and buses as the components in these larger vehicles-batteries, traction motors, power electronics, integrated chips, and advanced PCBs-are much harder to indigenize than those used in two- and three-wheelers.
Bu hikaye Mint Mumbai dergisinin September 13, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Mumbai'den DAHA FAZLA HİKAYE
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

